Proof of concept investigation to detect exposure of patients to Cytomegalovirus (CMV) and Herpes Simplex Virus-2 (HSV-2)
$223,323N43FY2017AINIH
Operational Technologies Corporation, San Antonio TX
Investigators
Abstract
To develop a tool to detect anti-CMV and anti-HSV-2 antibodies in human serum to determine and monitor viral status in patients.
View original record on NIH RePORTER →